Neuroprotection < Neuroprotective Agents < Neuropsychological Tests

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 52.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000241 (2015)	S. Abdelsayed [France] ; N T Ha Duong ; C. Bureau ; P P Michel ; E C Hirsch ; J M El Hage Chahine ; N. Serradji	Piperazine derivatives as iron chelators: a potential application in neurobiology.
000275 (2015)	Hocine Rekaik [France] ; François-Xavier Blaudin De Thé [France] ; Julia Fuchs [France] ; Olivia Massiani-Beaudoin [France] ; Alain Prochiantz [France] ; Rajiv L. Joshi [France]	Engrailed Homeoprotein Protects Mesencephalic Dopaminergic Neurons from Oxidative Stress.
000310 (2015)	Cristiane Latge [Brésil] ; Katia M S. Cabral [Brésil] ; Guilherme A P. De Oliveira [Brésil] ; Diana P. Raymundo [Brésil] ; Julia A. Freitas [Brésil] ; Laizes Johanson [Brésil] ; Luciana F. Romão [Brésil] ; Fernando L. Palhano [Brésil] ; Torsten Herrmann ; Marcius S. Almeida [Brésil] ; Debora Foguel [Brésil]	The Solution Structure and Dynamics of Full-length Human Cerebral Dopamine Neurotrophic Factor and Its Neuroprotective Role against α-Synuclein Oligomers.
000406 (2015)	Gael Le Douaron [France] ; Fanny Schmidt [France] ; Majid Amar [France] ; Hanane Kadar [France] ; Lucila Debortoli [Brésil] ; Alexandra Latini [Brésil] ; Blandine Séon-Méniel [France] ; Laurent Ferrié [France] ; Patrick Pierre Michel [France] ; David Touboul [France] ; Alain Brunelle [France] ; Rita Raisman-Vozari [France] ; Bruno Figadère [France]	Neuroprotective effects of a brain permeant 6-aminoquinoxaline derivative in cell culture conditions that model the loss of dopaminergic neurons in Parkinson disease.
000434 (2015)	Mariza Bortolanza [Brésil] ; Roberta Cavalcanti-Kiwiatkoski [Brésil] ; Fernando E. Padovan-Neto [Brésil] ; Célia Aparecida Da-Silva [Brésil] ; Miso Mitkovski [Allemagne] ; Rita Raisman-Vozari [France] ; Elaine Del-Bel [Brésil]	Glial activation is associated with l-DOPA induced dyskinesia and blocked by a nitric oxide synthase inhibitor in a rat model of Parkinson's disease.
000503 (2014)	Franziska Richter [États-Unis] ; Fuying Gao [États-Unis] ; Vera Medvedeva [États-Unis] ; Patrick Lee [États-Unis] ; Nicholas Bove [États-Unis] ; Sheila M. Fleming [États-Unis] ; Magali Michaud [France] ; Vincent Lemesre [États-Unis] ; Stefano Patassini [États-Unis] ; Krystal De La Rosa [États-Unis] ; Caitlin K. Mulligan [États-Unis] ; Pedrom C. Sioshansi [États-Unis] ; Chunni Zhu [États-Unis] ; Giovanni Coppola [États-Unis] ; Thierry Bordet [France] ; Rebecca M. Pruss [France] ; Marie-Françoise Chesselet [États-Unis]	Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neurons.
000507 (2014)	Anthony H V. Schapira [Royaume-Uni] ; C Warren Olanow [États-Unis] ; J Timothy Greenamyre [États-Unis] ; Erwan Bezard [France]	Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives.
000531 (2014)	David Devos [France] ; Caroline Moreau ; David Maltête ; Romain Lefaucheur ; Alexandre Kreisler ; Alexandre Eusebio ; Gilles Defer ; Thavarak Ouk ; Jean-Philippe Azulay ; Pierre Krystkowiak ; Tatiana Witjas ; Marie Delliaux ; Alain Destée ; Alain Duhamel ; Régis Bordet ; Luc Defebvre ; Kathy Dujardin	Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial.
000541 (2014)	César L. Ávila [Argentine] ; Clarisa M. Torres-Bugeau [Argentine] ; Leandro R S. Barbosa [Brésil] ; Elisa Morandé Sales [Brésil] ; Mohand O. Ouidja ; Sergio B. Socías [France] ; M Soledad Celej [Argentine] ; Rita Raisman-Vozari [France] ; Dulce Papy-Garcia ; Rosangela Itri [Brésil] ; Rosana N. Chehín [Argentine]	Structural characterization of heparin-induced glyceraldehyde-3-phosphate dehydrogenase protofibrils preventing α-synuclein oligomeric species toxicity.
000558 (2014)	V. Procaccio [France] ; C. Bris [France] ; J M Chao De La Barca [France] ; F. Oca [France] ; A. Chevrollier [France] ; P. Amati-Bonneau [France] ; D. Bonneau [France] ; P. Reynier [France]	Perspectives of drug-based neuroprotection targeting mitochondria.
000569 (2014)	P. Cesaro [France] ; L. Defebvre [France]	[Drug treatment of early-stage (de novo and "honeymoon") Parkinson disease].
000608 (????)	Murat Emre [États-Unis] ; Werner Poewe ; Peter Paul De Deyn ; Paolo Barone ; Jaime Kulisevsky ; Emmanuelle Pourcher ; Teus Van Laar ; Alexander Storch ; Federico Micheli ; David Burn ; Frank Durif ; Rajesh Pahwa ; Francesca Callegari ; Nadia Tenenbaum ; Christine Strohmaier	Long-term safety of rivastigmine in parkinson disease dementia: an open-label, randomized study.
000669 (2013)	Fanny Duval [France] ; Olivier Flabeau ; Julien Razafimahefa ; Umberto Spampinato ; François Tison	Encephalophaty associated with rasagiline and sertraline in Parkinson's disease: possible serotonin syndrome.
000712 (2013)	Daniel Alvarez-Fischer [France] ; Carmen Noelker ; Franca Vulinovi ; Anne Grünewald ; Caroline Chevarin ; Christine Klein ; Wolfgang H. Oertel ; Etienne C. Hirsch ; Patrick P. Michel ; Andreas Hartmann	Bee venom and its component apamin as neuroprotective agents in a Parkinson disease mouse model.
000731 (2013)	M. Amalric [France] ; S. Lopez ; C. Goudet ; G. Fisone ; G. Battaglia ; F. Nicoletti ; J-P Pin ; F C Acher	Group III and subtype 4 metabotropic glutamate receptor agonists: discovery and pathophysiological applications in Parkinson's disease.
000762 (2013)	Erwan Bezard [France] ; Zhenyu Yue ; Deniz Kirik ; Maria Grazia Spillantini	Animal models of Parkinson's disease: limits and relevance to neuroprotection studies.
000801 (2012)	Mickael Decressac [France] ; Stéphanie Pain ; Pierre-Yves Chabeauti ; Laura Frangeul ; Nathalie Thiriet ; Herbert Herzog ; Jackie Vergote ; Sylvie Chalon ; Mohamed Jaber ; Afsaneh Gaillard	Neuroprotection by neuropeptide Y in cell and animal models of Parkinson's disease.
000825 (2012)	Antoine Fouillet [France] ; Clemence Levet ; Angelique Virgone ; Marion Robin ; Pierre Dourlen ; Jennifer Rieusset ; Elise Belaidi ; Michel Ovize ; Monique Touret ; Serge Nataf ; Bertrand Mollereau	ER stress inhibits neuronal death by promoting autophagy.
000914 (2011)	Damien Toulorge [France] ; Serge Guerreiro ; Audrey Hild ; Uwe Maskos ; Etienne C. Hirsch ; Patrick P. Michel	Neuroprotection of midbrain dopamine neurons by nicotine is gated by cytoplasmic Ca2+.
000A75 (2010)	D. Devos [France] ; R. Bordet ; L. Defebvre	[Pharmacological hypotheses and therapeutic strategies for gait disorders in Parkinson's disease].
000B62 (2009)	Etienne C. Hirsch [France] ; Stéphane Hunot	Neuroinflammation in Parkinson's disease: a target for neuroprotection?

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i -k "Neuroprotective Agents" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i  \
                -Sk "Neuroprotective Agents" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Curation
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Neuroprotective Agents
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024